,
dissolved in water. Solvent B was 0.1% TFA dissolved in acetonitrile. The gradient used for peptide purification was 0% to 50% solvent B over 50 minutes. The purity of the synthesized peptides was assessed by C18 analytical column (5m 250x4.6mm Higgins Analytical) at a flow rate of 1 mL/min and gradient 10-60% B solvent over 50 minutes. Masses of the newly synthesized peptides were verified by MALDI-TOF-MS. and its mutants were dissolved with 0.1M Tris base (pH was not adjusted) to 60 mM. Peptide segments were incubated at 37°C with shaking level 9 in a Torrey Pine Scientific shaker. After 7 to 10 days the samples were examined by transmission electron microscope (TEM). (I149T) was crystallized using the hanging drop vapor diffusion method: 1l of 6mg/ml peptide dissolved in water was mixed with 2 l of reservoir solution. The drop was equilibrated over 1 ml of reservoir solution containing 0.1 M sodium acetate pH 4.5 and 0.7 M hexanediol.
DSVISLS 107
was crystallized using the hanging drop vapor diffusion method: after filtering with a 0.2µm filter, 1µL of 3 mg/mL peptide was mixed with 1 µL of reservoir solution, comprising 0.1 M MES pH 6.0, 20% PEG 6000, and 5 mM ZnCl 2 . Peptide crystals were mounted directly onto the ends of pulled glass capillaries.
X-ray diffraction and data processing: X-ray diffraction data were collected at beamline 24-ID-E of the Advanced Photon Source, Argonne National Laboratory, Argonne, IL, USA with a wavelength of 0.8954 Å and at beamline ID13 at the European Synchrotron Radiation Facility in Grenoble, France with a wavelength of 1.0332 Å. Data were collected at 100 K with 5° oscillations. Indexing of diffraction images was performed using the programs DENZO (2) or XDS (3) Scaling of data was performed using the program SCALEPACK (2) . The merged scaled data were imported into CCP4 format with programs from the CCP4 program suite organized under the "CCP4i" interface (4). Molecular replacement solutions were found using the program Phaser (5). In the case of after expanding dataset with SFTOOLS in the CCP4 suite (4) from P2 1 to P1. Crystallographic refinements were performed with the programs Refmac (7), Buster, and Phenix (8) . Model building was performed with COOT (6) and illustrated with PyMOL (9) . Area buried and shape complementarity were calculated with AREAIMOL (10) and SC (11), respectively.
X-ray powder diffraction of GIIGIAQ (V148I):
Aggregates of GIIGIAQ (V148I) grown in 0.1 M sodium phosphate pH 2.5 were pelleted by spinning the sample for 5 minutes at 20,000 x g. The pellet was scooped with a crystallization loop. Data was collected for 5 minutes with 1° oscillations using an in-house Rigaku RAXIS-4++ image plate detector (Rigaku-FRD).
Protein expression, purification and metal removal: Human SOD1 WT and SOD1
G93A
were expressed in the EGy118 strain of Saccharomyces cerevisiae (S. cerevisiae), which lacks the endogenous yeast sod1 gene. The proteins were purified and metals were removed as previously described in (12) , except that, in the last step, 25 mM potassium phosphate, pH 7.0, 1 mM EDTA were used as dialysis buffer. After metal removal, apoSOD1 WT .and apoSOD1
were immediately frozen and stored in -80°C. The protein was used within two weeks of freezing. In Fig. 5, Fig. S6 , Fig. S7 and Fig. S8 , assays are performed with SOD1 purified from S. cerevisiae. We also used human SOD1 with C6A and C111S substitutions (AS-SOD1) purified from Escherichia coli (E. coli). AS-SOD1 has similar properties to the wild-type protein (13), but lacks the two surface exposed Cys, which can cross link to form larger oligomers (14) . The plasmid with the AS-SOD1 gene was kindly provided by Becky Chan (Prof. Valentine lab). Pro mutations at positions I18P, I35P, I104P and I149P in the AS-SOD1 gene were made using QuickChange Site-Directed mutagenesis Kit (Stratagene). Proteins (wild-type and mutants) were expressed in the E. coli strain BL21(DE3) in the following way. Cells transformed with pET 22b vector containing AS-SOD1 gene, were grown in LB media containing 100g/ml ampicillin at 37°C with shaking. Cells were induced at OD 600 ~0.6 with 1 mM IPTG. ZnSO 4 was added to a final concentration of 0.05mM to aid protein folding. Then, cells were grown at 32°C. After 4 hours, the cells were harvested by centrifugation for 10-15 min at 4600xg. To release the protein from the periplasm, the cell pellet was resuspended in ice-cold 30 mM Tris-HCl pH 8, 20% sucrose (20-30ml for 1L growth media). Then, cells were stirred slowly at 4°C for 20 min. The cell slurry was spun at 10,000 × g at 4°C for 10 min and the supernatant was discarded. The cell pellet was resuspended in ice-cold water (20-30 ml for 1L growth media) and stirred slowly at 4°C for 20 min. During this step, the periplasmic proteins together with the expressed protein were released into the buffer. The cell suspension was centrifuged at 10,000xg for 10min. Ammonium sulfate was added to the supernatant which contained the expressed protein released by the double osmotic shock (0.326g ammonium sulfate per ml supernatant) and stirred at 4°C for 45min. This solution was centrifuged at 14,000xg for 30min. Then, the supernatant, containing the expressed protein, was mounted on a HiTrap Phenyl HP 5ml column (GE Healthcare). Solvent A was 2.5 M ammonium sulfate, 0.15 M sodium chloride, 0.05 M sodium phosphate, pH 7.0. Solvent B was 0.15 M sodium chloride, 0.05 M sodium phosphate, pH 7.0. Proteins were eluted by running a 100 ml gradient from 0% to 100% at 5ml/min. Finally, the protein was loaded on a size-exclusion silica G3000 column (Tosoh Bioscience). The column buffer comprised 0.1 M sodium sulfate, 25 mM sodium phosphate, and 1 mM sodium azide pH 6.5. To remove metals from AS-SOD1 and its mutants we followed the protocol described in (12) , except that, in the last step, 25 mM potassium phosphate, pH 7.0, 1 mM EDTA were used as dialysis buffer. Fibril formation assays were done immediately after the metal removal.
Fluorescence assays: Concentrated protein was thawed on ice and filtered through a 0.2m filter prior to the fibril formation assay. Fibril formation assays were performed with 17 M apoSOD1 WT and apoSOD1 G93A in 25 mM potassium phosphate buffer, pH 7.0, 1 mM EDTA, 35 mM Tris(2-carboxyethyl)phosphine (TCEP) and 10 M ThioflavinT. Under the conditions used, the SOD1 dimer is dissociated, so the molar concentrations of wild-type apoSOD1 WT and apoSOD1
were calculated using the molecular weight of the monomer. were made by dissolving the lyophilized peptide in 10mM potassium phosphate pH 7.0, 1mM EDTA. Peptides were added in the molar ratios indicated in Fig. 5A and B and Fig S6 and S7 . Aggregation assays of apoAS-SOD and its Pro mutants were performed with 35 M protein in 25mM sodium citrate pH 3.5, 1mM EDTA, 30 mM TCEP and 10 M ThioflavinT.
Seeding experiments were done using previously formed fibrils (prepared with 25 M protein; see above). 50 l of the pre-formed fibrils were pipetted in a glass NMR tubes and sonicated in a water bath for 15 minutes. After sonication the fibrils were diluted twice and 2 l were added for every 100 l reaction volume to make 2% seed solutions (v/v).
All assays were performed in black Nunc 96-well optical bottom plates (Thermo Scientific). Teflon balls (1/8 inch in diameter) were distributed into each well of the 96-well plate. Then, 150-200 μL of solution (four replicates per sample) were pipetted into each. The plate was agitated at 300 rpm with a 3-mm rotation diameter in a Varioskan microplate reader (Thermo) at 37 °C. Fluorescence measurements were recorded every 10-15 min by using λ ex = 444 nm, λ em = 482 nm, with an integration time of 200 μs. Description of data normalization and plotting can be found in the Supporting Information.
Normalization of the fluorescence data: For simplicity, in Fig. 5 the mean values of ThT fluorescence are displayed. The individual values, which were used to calculate the mean signal shown in Fig. 5 , were re-plotted in Fig. S6 . Similarly, Figs S7 and S8 were made by plotting the individual sample replicates. In all figures, the ThT fluorescence signal was corrected for the background by subtracting the mean fluorescence signal acquired during the first one to two hours of the assay. The fluorescence was also normalized by dividing each measurement by the mean signal collected for two to four hours during which the fluorescent reading had the largest value. If one of the sample replicates had fluorescence reading close to the background, its fluorescence was normalized by dividing it by the mean fluorescence reading of the remaining replicates. The data was smoothed by substituting each data point with the average value calculated using four data points collected prior and after the point and the point itself. This is equivalent to using a central moving average with a sliding nine data point window. The normalized fluorescence signal of the peptides ( ) incubated without the protein was calculated using the averaged fluorescence signal of maximum fluorescence acquired over two to three hours from the assays done with the largest peptide to protein ratios.
Transmission Electron Microscopy:
Negatively stained specimens for transmission electron microscopy (TEM) were prepared by applying 5 L of sample on hydrophilic 400 mesh carboncoated formvar support films mounted on copper grids (Ted Pella, Inc.). The samples were allowed to adhere for 3 min, rinsed twice with distilled water and stained for 1 min with 1% uranyl acetate. Grids were examined on either a JEM1200-EX (JEOL) or T12 (FEI) microscope. While these segments show no effect on protein aggregation, it is possible that under different experimental conditions these segments may become accessible for self-association. Each reaction was performed in triplicate and is represented by curves that are the same color. Table S1 : The effect of fALS-associated mutations on the fibril formation propensity of the SOD1 segments predicted to form fibrils: To compare the fibril formation propensity between segments longer than six residues, we calculated the average Rosetta energy for each sequence cluster (15 
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